Charles River Associates

For more than 50 years, we’ve delivered thoughtful, effective advice backed by research and real-world experience.

CRA acquires bioStrategies Group, Inc.

CRA welcomes bioStrategies Group, Inc. to CRA and the Life Sciences Practice. We’re excited to work together to bring valuable insights to our clients in the life sciences strategy sector.

Learn more here
Engagement on behalf of nation’s largest transportation companies

Dr. Timothy Snail provided expert economic analysis of class certification and damages issues on behalf of a joint defense group and settled defendants in a high-profile antitrust class action litigation.

Read the engagement here
Ozgur Kan joins CRA’s Financial Markets Practice as Vice President

“As a recognized expert who has provided written and oral testimony and expert advice in numerous domestic and international litigation and arbitration cases, Dr. Kan is a great fit for CRA,” said Stephen O’Neil, co-leader of CRA’s Finance Practice.

Learn more about Dr. Kan
Inflation Reduction Act: Increasing healthcare coverage, reducing healthcare prices

In this CRA Insights, Rhett Johnson and Matthew Majewski briefly summarize some of the most important changes associated with the IRA and highlight implications for life science manufacturers.

Learn more here